ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 0138 • ACR Convergence 2023

    Prevalence and Incidence of Sjögren’s Syndrome: A Systematic Literature Review

    Jiyoon Choi1, Kimberly Hofer2, Nishu Gaind2, Mir Sohail Fazeli2, Robert Carroll3, Antoine G Sreih3 and Antonia Christodoulou3, 1Bristol Myers Squibb, Lawrenceville, NJ, 2Evidinno Outcomes Research Inc., Vancouver, BC, Canada, 3Bristol Myers Squibb, Princeton Pike, NJ

    Background/Purpose: Sjögren's syndrome (SjS) is a chronic autoimmune disease that has been historically categorized into primary (manifesting alone; pSjS) or secondary (appearing alongside another underlying…
  • Abstract Number: 0467 • ACR Convergence 2023

    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals with Autoimmune Rheumatic Diseases and Antiphospholipid Syndrome

    Rashmi Dhital, Rebecca Baer and Christina Chambers, University of California San Diego, La Jolla, CA

    Background/Purpose: Autoimmune rheumatic diseases (ARD) and antiphospholipid syndrome (APS) are autoimmune conditions with increased risks of cardiovascular complications as well as negative pregnancy consequences. We…
  • Abstract Number: 0722 • ACR Convergence 2023

    Acute Cardiovascular Events in Autoimmune Rheumatic Disease Pregnancies

    Rashmi Dhital1, Rebecca Baer2, Monica Guma2, Kenneth Kalunian2, Accelerating Medicines Partnership Program RA SLE Network3 and Christina Chambers2, 1UC San Diego, San Diego, CA, 2University of California San Diego, La Jolla, CA, 3Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Cardiovascular diseases (CVDs) complicate 1-4% of pregnancies. Autoimmune rheumatic diseases (ARDs) are associated with a 1.5 to 3-fold higher CVD risk. Similarly, antiphospholipid syndrome…
  • Abstract Number: 0984 • ACR Convergence 2023

    Factors Associated with 5-year Mortality in Patients with Rheumatoid Arthritis Initiating Their First Biological or Target Synthetic DMARDs: A Nationwide, Population-based Cohort Study of 12,612 Patients

    Hsin-Hua Chen, Taichung Veterans General Hospital, Taichung, Taiwan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease resulting in increased mortality. manifestations. involvement. The National Health Insurance Research Database (NHIRD) in Taiwan…
  • Abstract Number: 1296 • ACR Convergence 2023

    Decline in Incidence of Extraarticular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study

    Bradly Kimbrough1, Cynthia Crowson1, John Davis1, Eric Matteson2 and Elena Myasoedova1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic College of Medicine and Science, Rochester, MN, USA, Rochester, MN

    Background/Purpose: Extraarticular manifestations of rheumatoid arthritis (ExRA) are associated with increased disease burden and mortality. They are also common, affecting about half of patients with…
  • Abstract Number: 1805 • ACR Convergence 2023

    Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake

    Sho Fukui1, Masato Okada2, Tomohiro Shinozaki3, Takahiro Asano2, Takehiro Nakai2, Hiromichi Tamaki2, Mitsumasa Kishimoto4, Hiroshi Hasegawa5, Takeaki Matsuda5, Javier Marrugo1, Sara Tedeschi1 and Daniel Solomon6, 1Brigham and Women's Hospital, Boston, MA, 2St. Luke's International Hospital, Tokyo, Japan, 3Tokyo University of Science, Tokyo, Japan, 4Kyorin University School of Medicine, Yokohoma, Japan, 5Kyorin University, Tokyo, Japan, 6Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Cross-sectional epidemiologic studies support a direct relationship between alcohol intake and serum urate (SU). These observations are parts of the basis for gout recommendations…
  • Abstract Number: 1957 • ACR Convergence 2023

    Non-Linear Mendelian Randomization Analyses Support a Role for Low Vitamin D Status in Sarcopenia Risk

    Tingting Sha1, Yilun Wang2, Yuqing Zhang3, Nancy Lane4, Changjun Li5, Jie Wei6, Chao Zeng2 and Guanghua Lei2, 1Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, China, 2Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 3Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 4University of California, Hillsborough, CA, 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China, 6Health Management Center, Xiangya Hospital Central South University, Changsha, China

    Background/Purpose: Vitamin D deficiency is commonly associated with sarcopenia; however, the latest International Clinical Practice Guidelines for Sarcopenia do not recommend vitamin D supplementation for…
  • Abstract Number: 2277 • ACR Convergence 2023

    Patients with Systemic Lupus Erythematosus: A Comparative Study Between Two Large, Multi-centric, Spanish and Argentinian Registers, Focused on Outcomes Differences

    Iñigo Rúa-Figueroa1, Rosana M Quintana2, JULIA MARTINEZ BARRIO3, Mercedes García4, Maria Galindo-Izquierdo5, Lucila Garcia6, Jaime Calvo- Alén7, Carla Gobbi8, Esther Uriarte Isacelaya9, Paula Alba8, Eva Tomero Muriel10, Verónica Bellomio11, Mercedes Freire González12, Susana Roverano6, Victor Martinez-Taboada13, Analia Patricia Alvarez14, Eva Salgado-Pérez15, Cesar Enrique Graf16, Paloma Vela17, Cecilia Pisoni14, Antonio Fernandez-Nebro18, Valeria Arturi19, Clara Sanguesa Gomez20, Catalina Gomez14, Javier Narvaez21, Zulema Plaza22, Gregorio Santos Soler23, Silvia Papasidero24, José Ángel Hernández Beriain25, Raul Paniego6, Angela Pecondón26, Maria Celina De La Vega6, Oihane Ibarguengoitia-Barrena27, Emma Civit8, Gema Bonilla28, Luciana Gonzalez Lucero14, Vicente Torrente-Segarra29, Maria Victoria Martire6, Ana Paula Cacheda30, Rodrigo Aguila Maldonado14, Maria J. García-Villanueva31, Sergio Gordon14, Clara Moriano Morales32, Marina Micelli6, Loreto Horcada33, Romina Nieto34, Nuria Lozano Rivas35, Gretel Rausch14, Guillermo Pons-Estel34 and Jose-Maria Pego-Reigosa36, 1Rheumatology, Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain, 2Centro Regional de Enfermedades Autoinmunes y Reumticas (CREAR), Grupo Oroño, Rosario, Argentina, 3Rheumatology, Gregorio Marañon University Hospital, Madrid, Spain, 4Hospital Interzonal General de Agudos José de San Martín, La Plata, Argentina, 5Rheumatology, University Hospital of 12 de Octubre, Madrid, Spain, 6RELESSAR, CABA, Argentina, 7Rheumatology, Bioaraba Research Unit, Hospital Universitario Araba, Vitoria, Spain, 8RELESSAR, Cordoba, Argentina, 9Rheumatology, University Hospital of Donosti, San Sebastián, Spain, 10Rheumatology, Hospital La Princesa, Madrid, Spain, 11RELESSAR, Tucuman, Argentina, 12Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 13Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain, 14Study Group of the Argentine Society of Rheumatology for Systemic Lupus Erythematosus, Buenos Aires, Argentina, 15Department of Rheumatology, University Hospital of Ourense, Ourense, Spain, 16RELESSAR, ENTRE RIOS, Argentina, 17Department of Rheumatology, University Hospital of Alicante, Alicante, Spain, 18Hospital Regional Universitario de Málaga, Malaga, Spain, 19RELESSAR, La Plata, Argentina, 20Severo Ochoa Hospital, Madrid, Spain, 21Hospital Universitario de Bellvitge, Barcelona, Spain, 22Universidad Autónoma de Madrid, Madrid, Spain, 23Rheumatology, Hospital Marina Baixa Villajoyosa, Alicante, Spain, 24Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 25Rheumatology, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain, 26Hospital Universitario Miguel Servet, Zaragoza, Madrid, Spain, 27Galdakao-Usansolo University Hospital, Bilbao, Spain, 28Department of Rheumatology, Hospital Clínico Universitario La Paz, Madrid, Spain, 29Department of Rheumatology, Hospital de Sant Joan Despí Moises Broggi,, Sant Joan Despí, Spain, 30Department of Rheumatology, Hospital Son Llatzer, Palma de Mallorca, Spain, 31Hospital Ramón y Cajal, Madrid, Spain, 32Rheumatology, Hospital Universitario de León, León, Spain, 33Hospital de Navarra, Pamplona, Spain, 34RELESSAR, Rosario, Argentina, 35Department of Rheumatology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, 36Rheumatology, Hospital do Meixoeiro, Vigo, Spain

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multi-organ involvement, associated with substantial morbidity and mortality. A characteristic that distinguishes lupus patients…
  • Abstract Number: 2516 • ACR Convergence 2023

    The Effect of Starting Prednisone Dose on the Treatment of Polymyalgia Rheumatica

    Katrina Nguyen1, Jennifer Du1, Jiaxiao shi2 and Antony Lin1, 1Kaiser SCAL, Fontana, CA, 2SCPMG, Pasadena, CA

    Background/Purpose: Polymyalgia rheumatica (PMR) is a systemic inflammatory syndrome that is characterized by widespread pain and stiffness around the shoulders, pelvic girdle and neck. PMR…
  • Abstract Number: 0139 • ACR Convergence 2023

    Systemic Vasculitides in Portugal and Brazil: Preliminary Results from the Reuma.pt/vasculitis Registry

    Mariana de Aguiar1, Alexandre wagner Silva de Souza2, Joana Martinho3, Adriana Carones4, Ana Beatriz Bacchiega de Freitas5, Ana Catarina Duarte6, Ana Filipa Águeda7, Camila Souto Oliveira Elias8, Catarina Cortesão9, Catarina Soares10, Carla Macieira11, Carlos Eduardo Garcez Teixeira12, Daniela Peixoto13, Duarte Vinha3, Estela Nogueira3, Fabricia Simil14, Francisca Guimarães13, Frederico Rajão Martins15, Gilda Ferreira16, Helena Assunção4, Heloisa Rulff8, Jorge Pestana Lopes6, José Costa3, Julia Medeiros17, Lilian Santos Porto18, Luiz Felipe Adsuara17, Manuella Ochtrop8, Maria João Gonçalves19, Mariana Diz Lopes20, Matheus Vieira21, Nikita Khmelinskii11, Rita Torres22, Sarah Neaime1, Vitor Teixeira23, Zoraida Sachetto12 and Cristina Ponte24, 1Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil, 2Division of Rheumatology, Medical School, Universidade Federal de São Paulo, São Paulo, Brazil, 3Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal, 4Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 5Faculdade de Ciências da Saúde de Barretos, Barretos, Brazil, 6Hospital Garcia de Orta, Almada, Portugal, 7Centro Hospitalar Universitário Cova da Beira, Covilhã, Portugal, 8Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 9Instituto Português de Reumatologia, Lisboa, Portugal, 10Centro Unidade Local de Saúde do Alto Minho, Viana do Castelo, Portugal, 11Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 12Universidade Estadual de Campinas, Campinas, Brazil, 13Centro Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal, 14Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 15Department of Rheumatology, University Hospital Centre of Algarve, Faro, Portugal, 16Federal University of Minas Gerais, Belo Horizonte, Brazil, 17Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil, 18Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil, 19Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal, 20Centro Hospitalar Universitário de São João, Porto, Portugal, 21Universidade Federal de São Paulo; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 22Hospital Egas Moniz, Lisboa, Portugal, 23Hospital de Faro, CHUA, Lisbon, Portugal, 24Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal

    Background/Purpose: The epidemiology of vasculitis varies widely across different geographic areas of the world which may be due to different ethnic and environmental factors. Brazil…
  • Abstract Number: 0477 • ACR Convergence 2023

    Continuing TNFi After Pregnancy Diagnosis in Women with Chronic Rheumatic Inflammatory Diseases Is Not Associated with Worse Obstetrical or Infant Outcomes and Seems to Reduce Risk of Maternal Severe Infection: The Results of the Emulated Target Trial BioGRIC

    Anna Molto1, aya ajrouche2, Diep Tran2, Nathalie Costedoat-Chalumeau3, Elisabeth Elefant4, Vassilis Tsatsaris5, Jeanne Fresson6, Brigitte Bader-Meunier5, Bruno Fautrel7 and Florence Tubach2, 1HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 2Centre de pharmaco-épidémiologie de l'APHP, Paris, France, 3Inserm DR Paris 5, Paris, France, 4APHP, Paris, France, 5Paris-Cité University, Paris, France, 6CHU Nancy, Nancy, France, 7Sorbonne Université APHP, Paris, France

    Background/Purpose: Many women with chronic rheumatic inflammatory diseases (CRID) stop tumor necrosis factor inhibitors (TNFi) treatment once pregnancy is confirmed to avoid potential adverse fetal…
  • Abstract Number: 0739 • ACR Convergence 2023

    Major Adverse Cardiovascular Event and Venous Thromboembolism Risk Comparing Advanced Therapies Among Individuals with Axial Spondylarthritis and Psoriatic Arthritis

    Sali Merjanah1, Devin Driscoll2, Christine Peloquin3, Jean liew3 and Maureen Dubreuil4, 1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 2Boston University/Boston Medical Center, Boston, MA, 3Boston University, Boston, MA, 4Department of Rheumatology, Boston University School of Medicine, Milton, MA

    Background/Purpose: Individuals with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) have increased cardiovascular risk compared to the general population, which is partly explained by systemic…
  • Abstract Number: 0985 • ACR Convergence 2023

    Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry

    Daniel Solomon1, Fredrik Johansson2, Hongshu Guan3, Leah Santacroce4, Lin Guo5, Wendi Malley5 and Heather Litman5, 1Brigham and Women's Hospital, Newton, MA, 2Chalmers University of Technology, Goteborg, Sweden, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5CorEvitas, LLC, Waltham, MA

    Background/Purpose: Comorbid conditions are very common in rheumatoid arthritis (RA) and several prior studies have derived comorbidity clusters using machine learning (ML). Clustering using ML…
  • Abstract Number: 1352 • ACR Convergence 2023

    Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study

    Yanint Raksadawan1, Aravind Polam1, Nattanicha Chaisrimaneepan2 and Sabahat Usmani1, 1Weiss Memorial Hospital, Chicago, IL, 2Texas Tech University Health Sciences, Lubbock, TX

    Background/Purpose: Takayasu's arteritis (TA) is a large vessel vasculitis which affects women of reproductive age. There is limited information about the effect of TA on…
  • Abstract Number: 1806 • ACR Convergence 2023

    The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis

    Daming Shao1, Jiyoung Seo1, Shaunak Mangeshkar1, Natalia Nazarenko1, Stepan Esagian1, Leonidas Palaiodimos1 and Damianos Kokkinidis2, 1Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, 2Yale University School of Medicine, New Haven, CT

    Background/Purpose: Cardiac sarcoidosis (CS) results from granulomatous infiltrating of the myocardium and manifests as an extended clinical spectrum from silence to conduction disturbances, ventricular tachyarrhythmias,…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology